LAB · Standard Biotools Inc. · Executive Compensation
Market Cap
$290.47M
Shares
392.58M
Volume · Oct 5
1.18M
Avg daily vol (3M)
1.68M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Michael Egholm | President, Chief Executive Officer, and Director | $8,823,502 |
| Alex Kim | Chief Financial Officer | $4,005,165 |
| Sean Mackay | Chief Business Officer | $1,692,543 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Michael Egholm | President, Chief Executive Officer, and Director | $8,337,044 |
| Sean Mackay | Chief Business Officer | $3,177,155 |
| Alex Kim | Chief Financial Officer | $3,090,340 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Michael Egholm | President, Chief Executive Officer, and Director | $1,931,088 |
| Jeffrey Black | Former Chief Financial Officer | $1,492,297 |
| Alex Kim | Chief Financial Officer | $909,788 |
| Sean Mackay | Chief Business Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Michael Egholm | President, Chief Executive Officer, and Director | $15,895,848 |
| Hanjoon Alex Kim | Chief Operating Officer | $5,856,938 |
| Alex Kim | Chief Financial Officer | $5,856,938 |
| Stephen Christopher Linthwaite | Former President and CEO | $1,638,601 |
| Jeremy Davis | Chief Commercial Officer | $1,404,172 |
| Jeffrey Black | Former Chief Financial Officer | — |
| Sean Mackay | Chief Business Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | Former President and CEO | $3,311,662 |
| Colin McCracken | Former Chief Commercial Officer | $1,386,353 |
| Vikram Jog | Chief Financial Officer | $1,105,664 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $920,559 |
| Bradley Kreger | Senior Vice President, Global Operations | $894,346 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | Former President and CEO | $3,800,867 |
| Colin McCracken | Former Chief Commercial Officer | $1,657,454 |
| Vikram Jog | Chief Financial Officer | $1,443,226 |
| Bradley Kreger | Senior Vice President, Global Operations | $1,385,499 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $1,050,529 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | Former President and CEO | $3,713,055 |
| Colin McCracken | Former Chief Commercial Officer | $1,911,764 |
| Vikram Jog | Chief Financial Officer | $1,391,445 |
| Bradley Kreger | Senior Vice President, Global Operations | $1,352,299 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $1,257,775 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | President and CEO | $2,585,213 |
| Vikram Jog | Chief Financial Officer | $1,125,539 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $1,091,461 |
| Bradley Kreger | Senior Vice President, Global Operations | $995,197 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | President and CEO | $2,019,870 |
| Vikram Jog | Chief Financial Officer | $974,126 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $925,210 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Eli Casdin | Class I director | Appointed | 2026-06-18 |
| Thomas Carey | Class I director | Appointed | 2026-06-18 |
| Michael Egholm, Ph.D. | Class I director | Appointed | 2026-06-18 |
| Spencer Smith | Chief Financial Officer | Appointed | 2026-06-08 |
| Dr. Jeff Engelman | Chief Scientific Officer | Appointed | 2026-06-08 |
| Dr. Josh Bilenker | Chief Executive Officer | Appointed | 2026-06-08 |
| Frank Witney, Ph.D. | Class III director | Appointed | 2025-06-20 |
| Kathy Hibbs | Class III director | Appointed | 2025-06-20 |
| Jeremy Davis | Chief Commercial Officer | Terminated | 2025-01-10 |
| Alex Kim | Chief Financial Officer | Appointed | 2024-11-07 |
| Alex Kim | Interim Chief Financial Officer | Appointed | 2024-07-31 |
| Jeffrey Black | Senior Vice President and Chief Financial Officer | Resigned | 2024-07-31 |
| Fenel M. Eloi | Class II director | Appointed | 2024-07-01 |
| Troy Cox | Class II director | Appointed | 2024-07-01 |
| Martin Madaus | Board of Directors | Resigned | 2024-01-05 |
| Carlos Paya | Board of Directors | Resigned | 2024-01-05 |
| Shane Bowen | Chief Technology Officer | Appointed | 2024-01-05 |
| Adam Taich | Chief Strategy Officer | Appointed | 2024-01-05 |
| Troy Cox | director | Appointed | 2024-01-05 |
| Tom Carey | Chairperson of the Standard BioTools Board | Appointed | 2024-01-05 |
| Tom Carey | director | Appointed | 2024-01-05 |
| Kathy Hibbs | director | Appointed | 2024-01-05 |
| Martin Madaus, Ph.D. | director | Resigned | 2024-01-05 |
| Laura Clague | director | Resigned | 2024-01-05 |
| Carlos Paya, M.D., Ph.D. | director | Resigned | 2024-01-05 |